Activities per year
- 37 results
Search results
-
10 ans de monitoring des anticoagulants oraux. Où en sommes-nous et où allons-nous?
Jonathan Douxfils (Speaker)
15 Mar 2022Activity: Talk or presentation types › Invited talk
-
30th Annual Meeting of the Belgian Society on Thrombosis and Haemostasis (BSTH)
Constant Gillot (Poster), Marie Didembourg (Poster) & Julie Vassart (Poster)
30 Nov 2023 → 1 Dec 2023Activity: Participating in or organising an event types › Participation in conference
-
Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Invited speaker)
24 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Acquired APC resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Speaker)
7 Oct 2022Activity: Talk or presentation types › Invited talk
-
Aquired APC-resistance as a marker for VTE, how reliable?
Jonathan Douxfils (Invited speaker)
27 Aug 2023Activity: Talk or presentation types › Invited talk
-
Beeak-out Medical: Hemostasis and update on the Post Authorization Safety Study
Jonathan Douxfils (Speaker) & Guillaume Chatel (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Combined Hormonal Contraceptives - Induced Coagulopathies Evaluation of the Prothrombotic State Using a Global Coagulation Assay
Jonathan Douxfils (Speaker) & Laure Morimont (Speaker)
4 Oct 2023Activity: Talk or presentation types › Invited talk
-
Correlation between activated protein C Resistance and the Relative Risk of Venous Thromboembolism in Women Using Hormonal Therapy
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
11 May 2022 → 14 May 2022Activity: Talk or presentation types › Oral presentation
-
Donesta Partner Meeting : Acquired APC resistance as a marker for VTE, how does the estrogens differ?
Jonathan Douxfils (Keynote speaker)
4 Sept 2023 → 8 Sept 2023Activity: Talk or presentation types › Invited talk
-
Drug monitoring of direct oral anticoagulants: Key considerations and prespectives
Jonathan Douxfils (Speaker)
3 Nov 2022Activity: Talk or presentation types › Invited talk
-
Estétrol: une nouvelle ère dans la contraception
Jonathan Douxfils (Invited speaker)
11 Feb 2023Activity: Talk or presentation types › Invited talk
-
Estétrol/drospirénone, le point de vue de l’hém(ost)ato(sio)logue
Jonathan Douxfils (Speaker)
26 Jan 2022Activity: Talk or presentation types › Invited talk
-
Estetrol (E4): a native estrogen whose effect on the liver does not need to be counterbalanced by progestins
Jonathan Douxfils (Speaker)
27 May 2022Activity: Talk or presentation types › Oral presentation
-
Fantastic 4 - E4stetrol in Women's Health
Jonathan Douxfils (Invited speaker) & Jean-Michel Foidart (Invited speaker)
4 May 2023 → 6 May 2023Activity: Talk or presentation types › Oral presentation
-
FIGO - XXIVe World Congress of Gynecology and Obstetrics
Jonathan Douxfils (Speaker)
9 Oct 2023 → 13 Oct 2023Activity: Participating in or organising an event types › Participation in conference
-
-
Global coagulation assays in the future of laboratory diagnostics of hemostasis and thrombosis - Interplay between platelets and coagulation
Jonathan Douxfils (Keynote speaker)
24 Nov 2022Activity: Talk or presentation types › Invited talk
-
Hormonal contraception and the risk of venous thrombosis – facts and myths
Jonathan Douxfils (Speaker)
18 Nov 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
17 May 2022Activity: Talk or presentation types › Invited talk
-
Impact des traitements hormonaux sur l’hémostase et exploration biologique : développement et perspectives actuelles
Jonathan Douxfils (Speaker)
7 Jun 2022Activity: Talk or presentation types › Invited talk
-
Impact of E4 on hemostasis — Key messages to understand its unique safety profile
Jonathan Douxfils (Speaker)
13 Sept 2022Activity: Talk or presentation types › Invited talk
-
Innovative applications of global assays in hemostatis
Jonathan Douxfils (Jury Member)
15 Dec 2023Activity: Examinations › External Thesis
-
ISTH 2022 Congress
Jonathan Douxfils (Contributor)
9 Jul 2022 → 13 Jul 2022Activity: Participating in or organising an event types › Participation in conference
-
ISTH 2023 Congress
Marie Didembourg (Poster) & Laure Morimont (Contributor)
24 Jun 2023 → 28 Jun 2023Activity: Participating in or organising an event types › Participation in conference
-
Low Thrombin Generation in Menopausal Women Using Estetrol (E4)
Laure Morimont (Speaker) & Jonathan Douxfils (Speaker)
26 Oct 2022Activity: Talk or presentation types › Oral presentation
-
L’associazione Estetrolo/Drospirenone: approfondimento sui parametri ematocoagulativi | Why APC resistance matters?
Jonathan Douxfils (Speaker)
14 Jun 2022Activity: Talk or presentation types › Invited talk
-
Method validation for haemostasis assays: Validation and standardization of the ETP-based activated protein C resistance test for the clinical investigation of steroid contraceptives in women. An unmet clinical and regulatory need
Jonathan Douxfils (Speaker)
15 Sept 2022Activity: Talk or presentation types › Invited talk
-
Monitoring des anticoagulants: Artéfacts ou avantages - Anticoagulants directs oraux
Jonathan Douxfils (Speaker)
20 Jun 2022Activity: Talk or presentation types › Invited talk
-
Navigating new regulations in biobanking for clinical studies and research projects
Jonathan Douxfils (Speaker)
4 Oct 2023Activity: Talk or presentation types › Oral presentation
-
NETosis and Nucleosome Biomarkers in Septic Shock and Critical COVID-19 Patients: An Observational Study
Laure Morimont (Speaker)
27 Apr 2023Activity: Talk or presentation types › Oral presentation
-
Prediction Of Venous Thromboembolism Risk Associated With Combined Oral Contraceptives: An Exploratory Model
Laure Morimont (Speaker)
19 May 2023Activity: Talk or presentation types › Oral presentation
-
Risque induit par les oestrogènes de synthèse en clinique
Jonathan Douxfils (Invited speaker)
8 Jun 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4: Recent advance and evidence
Jonathan Douxfils (Keynote speaker)
18 Sept 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Speaker)
14 Nov 2023Activity: Talk or presentation types › Invited talk
-
Safety profile of E4 Recent advance and evidence
Jonathan Douxfils (Invited speaker)
7 Nov 2023Activity: Talk or presentation types › Invited talk
-
Serum SARS-CoV-2 Antigens for the Determination of COVID-19 Severity
Jonathan Douxfils (Speaker)
4 Jul 2022Activity: Talk or presentation types › Invited talk
-
Thromboembolie veineuse et contraception orale: Quelle stratégie pour minimiser le risque?
Jonathan Douxfils (Invited speaker) & Laure Morimont (Speaker)
12 Jan 2023Activity: Talk or presentation types › Invited talk